Page 8 of 12

ASCO 2017: Abstract Recommendations From Dr. Axel Grothey

Posted: Thu Jun 01, 2017 4:20 pm
by CRguy
Upcoming ASCO 2017 sessions as highlighted by a leading expert.

ASCO 2017: Abstract Recommendations From Dr. Axel Grothey—Colorectal Cancer

List of recent Editor's Picks, Expert Opinions, Journal Scans and News releases from the Expert Panel at Practice Update
Summary of CRC journal scans and opinions

Quickly reporting cancer complications may boost survival

Posted: Tue Jun 06, 2017 10:56 pm
by CRguy
Quickly reporting cancer complications may boost survival

Patients were able to stick with treatment longer because their side effects were quickly addressed, he said.

New Cancer Drug Is So Effective Against Tumors, the FDA Approved It Immediately

Posted: Mon Jun 12, 2017 8:23 am
by Utwo
New Cancer Drug Is So Effective Against Tumors, the FDA Approved It Immediately is about Merck Keytruda.

Apparently "Approved It Immediately" in a title is an exaggeration.
They have not shared neither cost nor duration of the approval process.

Re: ***News Stories Thread*** ONGOING 2017

Posted: Mon Jun 12, 2017 10:57 am
by mpbser ... 123928.htm

Ontario-grown red onions are the most effective at killing colon and breast cancer cells compared to other types of onions, reports a new study. This is because of the onions' high levels of quercetin and anthocyanin. As part of this project, the researchers are also the first to develop a non-toxic way to extract quercetin from onions making it more suitable for consumption.

SUNSHINE: High-Dose Vitamin D Improved PFS in Colorectal Cancer

Posted: Wed Jun 14, 2017 9:00 am
by garbovatwin

Re: ***News Stories Thread*** ONGOING 2017

Posted: Fri Jun 16, 2017 5:19 am
by mpbser

Protect Yourself: Get a Second Medical Opinion

Posted: Sun Jun 18, 2017 11:07 am
by Utwo

"Fraudulent oncologist Dr. Farid Fata falsely diagnoses hundreds of patients and inflicts excessive cancer treatments on them — all for the $17 million he gets from insurance companies and Medicare. American Greed’s Scott Cohn reports on the importance of getting another doctor’s opinion when you get a serious diagnosis."

Re: ***News Stories Thread*** ONGOING 2017

Posted: Tue Jun 20, 2017 12:00 pm
by Steph20021 ... l-benefit/

Dual HER2 targeting of HER2 positive metastatic colon cancer

Re: Task Force Releases Updated Recommendations for Colorectal Cancer Screening

Posted: Tue Jun 27, 2017 1:18 pm
by Jacques

This report contains several recommendations, one of which would be of particular interest to younger members of this Forum:

* Adults age younger than 50 years with colorectal bleeding symptoms should undergo colonoscopy or an evaluation sufficient to determine a bleeding cause, initiate treatment and complete follow-up to determine resolution of bleeding.

An omega-3 rich diet really can fight bowel cancer: ...

Posted: Thu Jun 29, 2017 5:46 am
by waw4
(study) ... ancer.html

salmon, walnuts, chia seeds ...

Personalized Cancer-Cell Sequencing

Posted: Mon Jul 03, 2017 11:52 am
by Maggie Nell
"We also need to understand the complexity of cancer and how cancer is very clever, and these new technologies
that we'll bring to Perth will allow us to understand the complexity and hopefully be much cleverer than the cancer." ... ng/8671596

How prudishness of Americans and shyness/hypocrisy of American politicians kill people due to inefficient allocation of

Posted: Wed Jul 05, 2017 7:04 am
by Utwo

Declaring the idea of cost effectiveness a “forbidden topic in the health care debate,” Aaron Carroll shows just how adverse we are to the idea of comparing money cost with health outcomes. It’s even written into the Affordable Care Act:

"… we in the United States are so averse to the idea of cost effectiveness that when the Patient Centered Outcomes Research Institute, the body specifically set up to do comparative effectiveness research, was founded, the law explicitly prohibited it from funding any cost-effectiveness research at all. As it says on its website, 'We don’t consider cost effectiveness to be an outcome of direct importance to patients.'"

Tengs, along with Professor John Graham and a team of researchers at the Harvard Center for Risk Analysis, systematically gleaned from the literature annual cost and lifesaving effectiveness information for 185 interventions. Some of these interventions had been fully implemented, some partially implemented and some not implemented all. The researchers then asked: what if we reallocated funds from regulations and procedures that give us a low rate of return to those procedures that give us a high one?

The 185 interventions cost about $21.4 billion per year and saved about 592,000 years of life.
If that same money had been spent on the most cost-effective interventions, however, 1,230,000 years of life could have been saved -- about 638,000 more years of life than under the status quo.

flax seeds and pomegranate

Posted: Wed Jul 05, 2017 8:51 am
by mpbser

Negotiating Cancer: 8 tips from Stefanie Joho

Posted: Sun Jul 09, 2017 2:12 am
by Maggie Nell ... ft09a-5gp1

At the age of 24, after two surgeries and two aggressive rounds of chemotherapy failed to cure me, my oncologist sent me home to die. When I was first diagnosed with colon cancer in 2013, I'd never even heard the word immunotherapy. ....Because I'm one of the very few lucky ones who looked into the abyss and made it out on the other side, I feel it is my duty to speak up and share some of the critical things that I have learned in what is now a new era in cancer care. Because a disease that should have killed me instead launched my career in patient advocacy.

5. Clinical trials are not a last-resort option.

The lines of treatment are rapidly changing, and, more often than not, getting access to cutting-edge treatments entails enrolling in a clinical trial. There's an unfortunate misconception that clinical trials are reserved for those who have exhausted all other options. In reality, trials can actually offer access to the most individualized cancer treatment. And in fact, immunotherapy is more and more becoming the first line of treatment - and even being used before surgery to prevent relapses.

And just as individual patients can't tackle their disease by themselves, we all ultimately must help one another by sharing and participating in clinical trials. Only 4 percent of cancer patients are currently enrolled in studies. Explore trials at cancer centers with a lot of experience in the type of therapy being tested. See if you have options outside of what has been standard of care for 70-plus years.

In the doctor-patient relationship, patients must understand that they are partners of science and as big a part of the cure as doctors. Without us, and our willingness to participate, medical advances would not exist. I will always feel a tremendous sense of pride for participating in a study that will save many thousands of people's lives.

Bowel Cancer Fueled by Drinking Alcohol

Posted: Sun Jul 09, 2017 2:24 pm
by Jacques